JOVANA
Library Glossary Getting Started Three Levels Fields How it works Mission
Join the mission
All guides

Organ Toxicity & Therapeutic Drug Monitoring

The liver and kidneys take the brunt of drug harm. Learn how hepato- and nephrotoxicity arise, and how therapeutic drug monitoring uses blood levels to keep narrow-margin drugs both effective and safe.

Why liver and kidney bear the brunt

Two organs see the highest concentrations of drugs and their breakdown products, so they take the most damage. The liver metabolizes nearly everything, and in doing so can create a reactive metabolite that injures liver cells — that is hepatotoxicity. The kidneys filter and concentrate drugs for renal excretion, so toxic compounds reach high levels in the tubules, causing nephrotoxicity.

Organ toxicity has a vicious feedback loop. A drug cleared by the kidney that also damages the kidney will reduce its own renal clearance, so it accumulates and does still more harm. This is why a damaged liver or kidney is itself a reason to lower doses — the very organ that disposes of the drug is failing, letting levels climb. Watching organ function (liver enzymes, kidney markers) is a core part of pharmacovigilance.

Therapeutic drug monitoring: measuring to stay safe

For most drugs we dose by guidelines and watch the patient. But some drugs are too risky for that. Therapeutic drug monitoring (TDM) means measuring the actual blood concentration and adjusting the dose to land inside the therapeutic window. TDM earns its place when three things are true: the window is narrow, the effect is hard to read by eye, and blood level tracks effect and toxicity well.

Classic TDM drugs include aminoglycoside antibiotics, digoxin, lithium, some antiepileptics, and several immunosuppressants. Timing the blood sample matters enormously: you usually wait until steady state (about four to five half-lives after starting or changing a dose) and you measure a trough — drawn just before the next dose — because the trough best reflects whether the drug is accumulating to harmful levels.

TDM decision loop

1. Start dose by weight / renal function
2. Wait ~4-5 half-lives -> steady state reached
3. Draw level at the right time
     trough = just before next dose (reflects accumulation)
     peak   = fixed time after dose (reflects efficacy)
4. Compare to target therapeutic window
     below window -> increase dose
     above window -> decrease / hold dose
5. Re-check after each change
TDM turns a guess into a measurement, then a measurement into a safe dose.

Reading a level, not just a number

  1. Confirm timing: a level drawn before steady state, or at the wrong point in the dosing interval, can mislead badly.
  2. Treat the patient, not the number: act on toxicity signs even if the level looks acceptable, and the reverse.
  3. Re-check organ function: failing renal clearance means today's safe dose may be tomorrow's overdose.